Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 1/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4066744 | 1.00 | PTPRC (0.57) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL3626587 | 1.00 | PTPRC (0.57) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL1152 | 1.00 | PTPRC (0.57) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| Phosphoric Acid SCHEMBL27545043 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| Phosphine SCHEMBL28192584 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL29567635 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| Phosphoric Acid SCHEMBL3476886 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL19615883 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL29613927 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI | |
| SCHEMBL27947556 | 0.98 | PTPRC (0.56) | PTPRCSLC7A5PTPN1PTGS1ALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 834 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119735180-A | Hydroxyapatite microsphere and preparation method thereof | 北京纳通医学研究院有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-118356523-A | Solid phase composition of bone adhesive for oral cavity, preparation method thereof and bone adhesive | 北京纳通医学科技研究院有限公司 | 2024-07-19 | — | — | CN | claimed |
| CN-118146349-A | Modified polypeptide and application thereof | 井冈山大学 | 2024-06-07 | — | — | CN | claimed |
| CN-116773710-A | Kit for covering metabolome and metabolic flow of multiple metabolites and use method | 清华大学 | 2023-09-19 | — | — | CN | claimed |
| US-20230287510-A1 | COMPOSITIONS, PANELS, AND METHODS FOR CHARACTERIZING CHRONIC LYMPHOCYTIC LEUKEMIA | THE BROAD INSTITUTE, INC. (US) | 2023-09-14 | — | — | US | claimed |
| CN-113624862-B | Metabolome covering multiple metabolites, metabolic flux analysis method and kit | 清华大学 | 2023-04-07 | — | — | CN | claimed |
| WO-2022035723-A1 | COMPOSITIONS, PANELS, AND METHODS FOR CHARACTERIZING CHRONIC LYMPHOCYTIC LEUKEMIA | THE BROAD INSTITUTE, INC. (US) | 2022-02-17 | — | — | WO | claimed |
| US-10030225-B2 | Cell culture media | MERCK PATENT GMBH (DE) | 2018-07-24 | — | — | US | claimed |
| EP-2920296-B1 | CELL CULTURE MED | MERCK PATENT GMBH (DE) | 2018-07-18 | — | — | EP | claimed |
| US-20170306504-A1 | CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USING SAME | CHAMPIONX LLC | 2017-10-26 | — | — | US | claimed |
| CN-101541955-A | Hybrid suppressor tRNA for vertebrate cells | AMBRX INC (US) | 2009-09-23 | — | — | CN | claimed |
| US-20090209508-A1 | Compounds for Photochemotherapy | UNIVERSITE DE GENEVE (CH) | 2009-08-20 | — | — | US | claimed |
| CN-101511856-A | Suppressor TRNA transcription in vertebrate cells | AMBRX INC (US) | 2009-08-19 | — | — | CN | claimed |
| CN-101223272-A | Expanding the eukaryotic genetic code | SCRIPPS RESEARCH INST (US) | 2008-07-16 | — | — | CN | claimed |
| EP-1888115-A2 | COMPOUNDS FOR PHOTOCHEMOTHERAPY | UNIVERSITE DE GENEVE (CH) | 2008-02-20 | — | — | EP | claimed |
| WO-2007023398-A2 | COMPOUNDS FOR PHOTOCHEMOTHERAPY | UNIVERSITE DE GENEVE (US) | 2007-03-01 | — | — | WO | claimed |
| US-5858244-A | COPOLYMER COMPRISING AT LEAST ONE OF N-OXYGENATEDHYDROCARBONAMIDE MONOMERS AND AT LEAST ONE OF AMINO ACID MONOMERS, POLYSUCCINIMIDES | NALCO CHEMICAL COMPANY (US) | 1999-01-12 | — | — | US | claimed |
| US-5776875-A | Use of biodegradable polymers in preventing scale build-up | NALCO CHEMICAL COMPANY (US) | 1998-07-07 | — | — | US | claimed |
| US-5767158-A | FOR BLEACHING SKIN | SHISEIDO CO., LTD. (JP) | 1998-06-16 | — | — | US | claimed |
| EP-0819653-A2 | Use of biodegradable polymers in preventing scale build-up | NALCO CHEMICAL COMPANY (US) | 1998-01-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10030225-B2 | Cell culture media | SRC, PTPN4, PTPN6 | PTPRC 30/4885SLC7A5 423/4885PTPN1 7/4885 |
| US-20230287510-A1 | COMPOSITIONS, PANELS, AND METHODS FOR CHARACTERIZING CHRONIC LYMPHOCYTIC LEUKEMIA | BCL9, BCL9L, BCL6B | PTPRC 47/4885SLC7A5 4723/4885PTPN1 529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.